Press Releases

January 10, 2022
IN8bio to Present at Upcoming January Investor Conferences
PDF Version
January 6, 2022
IN8bio Announces Clinical Updates from the Phase 1 Clinical Trial of its Genetically Modified Gamma-Delta T Cell Therapy in Newly Diagnosed Glioblastoma Multiforme
PDF Version